Home / News Type Content Tools: Save | Print | E-mail | Most Read | Comment
Teamwork Takes on Fake Drugs
Adjust font size:  ZoomIn ZoomOut

Multinational pharmaceutical companies in China are calling on the government to take tougher measures to protect drug intellectual property rights (IPR) while pushing forward the domestic innovation of new drugs and attracting more foreign direct investment.

 

"The Chinese Government has been actively working with pharmaceutical companies to fight against counterfeits. And the progress in protecting the IPR of new drugs in the past years has been great," said Peter Scheuer, executive director of China's research and development (R&D)-based Pharmaceutical Association.

 

According to a recent report from the International Federation of Pharmaceutical Manufacturers' Associations, China is the most suitable country to take part in global drug innovation among all developing countries due to the support from its government, its IPR protection and its industry's infrastructure.

 

Since 1993 in China, applications by groups for IPR protection have maintained double-digit growth. And the public is gaining an improving awareness about IPR.

 

Pharmaceutical companies have received 20-year patent terms for their new drugs and six-years of data exclusivity after China became a World Trade Organization member.

 

The association also said, in the future, it will discuss with the government about prolonging the drugs patent-term as many new drugs get approvals in China two or three years later than in other countries.

 

Despite the government's arduous efforts to fight counterfeit drugs, China still has quite a long way to go to protect drug IPR.

 

"More strong measures should be taken to punish counterfeiters, which aims to build the confidence in drug R&D," said Scheuer.

 

The association estimates that about 8 percent of over the counter drugs sold in China are counterfeit.

 

"To develop a new drug is a highly risky and expensive project, so it's essential to protect the new drug's IPR. Generally, it takes about 12 to 15 years to develop a new drug with a total investment up to US$20.2 million," said Feng Danlong, director of Corporate Affairs at Pfizer Pharmaceuticals Ltd, a famous US-based drugs maker.

 

China has about 6,800 pharmaceutical companies but most are small and inefficient. They cannot invest large sums of money in new drugs.

 

"Because of the great potential of the market and the optimistic future of IPR in China, we are pushing our headquarters to set up an R&D center here," said James Liu, president of Beijing Novartis Pharma Ltd under Switzerland-based pharmaceutical giant Novartis.

 

(China Daily September 3, 2003)

Tools: Save | Print | E-mail | Most Read
Comment
Pet Name
Anonymous
China Archives
Related >>
- Laws to Be Revised to Hail Creativity
- First Intellectual Property Agency Set up in Shanghai
- Courts Speed up Ways to Deal with IPRs
- Customs, Businesses Join Hands in IP Protection
- China Steps up Legislation for Intellectual Protection
- Copyright of Folk Song Under Protection
- Talks to Focus on IPR Protection
- Beijing's IPR Workload Soars
- Patents Crucial to Scientific Projects
-
Most Viewed >>
- World's longest sea-spanning bridge to open
- Yao out for season with stress fracture in left foot
- 141 seriously polluting products blacklisted
- China starts excavation for world's first 3G nuclear plant
- 'The China Riddle'
- Irresponsible remarks on Hu Jia case opposed 
- China, US agree to step up constructive,cooperative relations
- Factory fire kills 15, injures 3 in Shenzhen
- FIT World Congress: translators on track
- Christianity popular in Tang Dynasty

Product Directory
China Search
Country Search
Hot Buys
主站蜘蛛池模板: 欧美日韩精品一区二区在线播放| 国产三级小视频| 亚洲综合久久一本伊伊区| xxxx日本在线| 欧美三级在线观看不卡视频| 午夜精品久久久久久久无码| youjizz亚洲| 小明发布永久在线成人免费| 亚洲va久久久噜噜噜久久| 精品一区二区三区免费毛片| 国产欧美日韩亚洲| www.99在线| 日本毛茸茸的丰满熟妇| 亚洲欧美日韩网站| 老湿影院在线观看| 国产精品国产亚洲精品看不卡 | 伊人色在线观看| 青青青国产在线观看免费网站| 国产鲁鲁视频在线观看| 中文字幕成人精品久久不卡| 欧美fxxx性| 人妻中文字幕无码专区| 色综合久久天天影视网| 国产精品亚洲片在线观看不卡| 一级做a爱片久久毛片| 日韩精品一区二区三区免费视频 | 亚洲国产综合精品| 精品人妻AV无码一区二区三区| 国产国产人免费人成免费视频| 91精品欧美成人| 成人性生活免费看| 久久精品这里有| 欧美精品亚洲精品日韩专区va| 卡一卡2卡3卡精品网站| 高贵娇妻被多p| 国产综合第一页| а天堂中文最新一区二区三区| 日日躁夜夜躁狠狠躁超碰97| 亚洲国产精品综合久久20| 欧美色图亚洲天堂| 免费的看黄网站|